Patents by Inventor Katherine Epler

Katherine Epler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRLF-2 BINDING PEPTIDES, PROTOCELLS AND VIRAL-LIKE PARTICLES USEFUL IN THE TREATMENT OF CANCER, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Publication number: 20150010475
    Abstract: The present invention relates to the use of which are attached or anchored phospholipid biolayers further modified by CRLF-2 and CD 19 binding peptides which may be used for delivering pharmaceutical cargos, to cells expressing CRLF-2 and CD 19, thereby treating cancer, in particular, acute lymphoblastic leukemia (ALL), including (B-precursor acute lymphoblastic leukemia (B-ALL). Novel CRLF-2 binding peptides and CLRF-2 and CD19-binding viral-like particles (VLPs) useful in the treatment of cancer, including ALL are also provided.
    Type: Application
    Filed: December 31, 2012
    Publication date: January 8, 2015
    Applicants: SANDA CORPORATION
    Inventors: C. Jeffrey Brinker, David S. Peabody, Walker Kip Wharton, Bryce Chackerian, Carlee Erin Ashley, Cheryl L. Willman, Eric C. Carnes, Katherine Epler, Robert Eric Castillo